Variant report
Variant | esv3442930 |
---|---|
Chromosome Location | chr2:21205632-21205966 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:21203233..21206131-chr2:21209365..21210977,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs72890789 | chr2:21205653-21205654 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs562577992 | chr2:21205678-21205679 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs374082988 | chr2:21205705-21205706 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571411031 | chr2:21205760-21205761 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530619287 | chr2:21205777-21205778 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs78139328 | chr2:21205796-21205797 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567225541 | chr2:21205818-21205819 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376036789 | chr2:21205842-21205843 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs115718138 | chr2:21205889-21205890 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs35131127 | chr2:21205914-21205915 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs566408650 | chr2:21205915-21205916 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs62120847 | chr2:21205920-21205921 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 16751803 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ependymoma | 16718352 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Neuroblastoma | 19638189 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Neuroblastoma | 18574593 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Medulloblastoma | 22160402 | CNVD |
Schizophrenia | 22118685 | CNVD |
Epilepsy | 22118685 | CNVD |
Breast cancer | 21509527 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 17908972 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Neuroblastoma | 18765546 | CNVD |
Neuroblastoma | 18281664 | CNVD |
Neuroblastoma | 17289879 | CNVD |
Neuroblastoma | 19738985 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:21200000-21206400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
2 | chr2:21200200-21207000 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
3 | chr2:21201200-21206400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr2:21201400-21205800 | Weak transcription | Fetal Muscle Leg | muscle |
5 | chr2:21203800-21206800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr2:21204800-21207000 | Enhancers | Fetal Muscle Trunk | muscle |
7 | chr2:21205200-21206800 | Weak transcription | Stomach Smooth Muscle | stomach |
8 | chr2:21205400-21206000 | Enhancers | Fetal Kidney | kidney |
9 | chr2:21205600-21208600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr2:21205800-21206200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
11 | chr2:21205800-21207400 | Enhancers | Fetal Muscle Leg | muscle |